Ovid Therapeutics (1OT.F) Q3 2025 Earnings

Aug 13Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.19
-0.15
-0.1
-0.05

Details

Expected EPS
-0.13479499593
Actual EPS
-0.0512298
Surprise EPS
0.08
Surprise Percent
+61.99%

Description

⁨Ovid Therapeutics⁩ (⁦1OT.F⁩) has reported earnings of ⁦-0.0512298⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts